Cost comparison of catheter ablation and medical therapy in atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 9, 2007, Pages 907-913

  Khaykin, Yaariv ^a   Morillo, Carlos A ^b   Skanes, Allan C ^c   McCracken, Aaron ^d   Humphries, Karin ^e   Kerr, Charles R ^e  

^a SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d JOHNSON AND JOHNSON   (United States)

^e ST PAUL S HOSPITAL   (Canada)

Author keywords

Atrial fibrillation; Catheter ablation; Health economics; Pulmonary veins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CANADA; CATHETER ABLATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; ECHOCARDIOGRAPHY; FOLLOW UP; GOVERNMENT; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL BILLING; HUMAN; MEDICAL CARE; MEDICAL FEE; NON INVASIVE PROCEDURE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PREVALENCE; PRIORITY JOURNAL; PULMONARY VEIN; SENSITIVITY ANALYSIS;

ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HUMANS; ONTARIO; PREVALENCE;

EID: 34548337198     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00902.x     Document Type: Article

References (41)

1. Camm AJ, Obel OA : Epidemiology and mechanism of atrial fibrillation and atrial flutter. Am J Cardiol 1996 78 : 3 11.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D : Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998 98 : 946 952.
3. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB : Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998 158 : 229 234.
4. Connolly SJ : Preventing stroke in atrial fibrillation: Why are so many eligible patients not receiving anticoagulant therapy? CMAJ 1999 161 : 533 534.
5. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD : A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 1833.
6. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J : Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998 339 : 659 666.
7. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS : Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999 100 : 1879 1886.
8. Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhofer I, Chauvin M, Garrigue S, Clementy J : Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000 102 : 2463 2465.
9. Natale A, Pisano E, Shewchik J, Bash D, Fanelli R, Potenza D, Santarelli P, Schweikert R, White R, Saliba W, Kanagaratnam L, Tchou P, Lesh M : First human experience with pulmonary vein isolation using a through- the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 2000 102 : 1879 1882.
10. Pappone C, Oreto G, Lamberti F, Vicedomini G, Loricchio ML, Shpun S, Rillo M, Calabro MP, Conversano A, Ben-Haim SA, Cappato R, Chierchia S : Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999 100 : 1203 1208.
11. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabro MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfieri O : Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001 104 : 2539 2544.
12. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S : Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000 102 : 2619 2628.
13. Marrouche NF, Dresing T, Cole C, Bash D, Saad E, Balaban K, Pavia SV, Schweikert R, Saliba W, Abdul-Karim A, Pisano E, Fanelli R, Tchou P, Natale A : Circular mapping and ablation of the pulmonary veins for treatment of atrial fibrillation. Impact of different catheter technologies. J Am Coll Cardiol 2002 40 : 464 474.
14. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V, Tortoriello V, Sala S, Zangrillo A, Crescenzi G, Benussi S, Alfieri O : Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003 42 : 185 197.
15. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC : Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 2004 43 : 241 247.
16. Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, Roy D : Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002 143 : 984 990.
17. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG : Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004 109 : 1509 1513.
18. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ : A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002 347 : 1834 1840.
19. Mittmann N, Oh PI, Walker SE, Bartle WR : Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: Impact of bioavailability on costs and outcomes. Pharmacoeconomics 2004 22 : 671 683.
20. Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, Sheldon R, Talajic M, Dorian P, Newman D : New-onset atrial fibrillation: Sex differences in presentation, treatment, and outcome. Circulation 2001 103 : 2365 2370.
21. Ontario Drug Benefit Formulary. 2004. Cited; available from : http://www.health.gov.on.ca/english/providers/program/drugs/odbf_eformulary.html
22. Moeremans K, Aliott E, Chillou CD, Annemans L, Pen CL, Jong PD : Second line pharmacological management of paroxysmal and persistent atrial fibrillation in France: A cost analysis. Value Health 2000 3 : 407 416.
23. Wolf PA, Dawber TR, Thomas HE Jr., Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978 28 : 973 977.
24. Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, Rossillo A, Verma A, Cummings J, Erciyes D, Saad E, Bhargava M, Bash D, Schweikert R, Burkhardt D, Williams-Andrews M, Perez-Lugones A, Abdul-Karim A, Saliba W, Natale A : Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 2004 43 : 1004 1409.
25. Khaykin Y, Marrouche NF, Saliba W, Schweikert R, Bash D, Chen MS, Williams-Andrews M, Saad E, Burkhardt DJ, Bhargava M, Joseph G, Rossillo A, Erciyes D, Martin D, Natale A : Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm 2004 1 : 33 39.
26. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M : Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004 351 : 2373 2383.
27. Ontario Ministry of Health and Long-term Care Physician Schedule of Benefits. 2003.
28. Verma A, Marrouche NF, Natale A : Pulmonary vein antrum isolation: Intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol 2004 15 : 1335 1340.
29. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A : Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005 111 : 1100 1105.
30. Noorani HZ, Yee R, Marshall D, Connolly S, Nichol G, O'Brien B : Radiofrequency catheter ablation for cardiac arrhythmias: A clinical and economic review, in Canadian Coordinating Office for Health Technology Assessment. 2002, Canadian Coordinating Office for Health Technology Assessment.
31. Health Costing in Alberta. 2003. Annual Report.
32. Calgary Health Region Price Guide 2005-06.
33. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A : Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005 293 : 2634 2640.
34. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr., Bates ER, Lehmann MH, Vicedomini G, Augello G, Agricola E Sala S, Santinelli V, Morady F : Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006 354 : 934 941.
35. Jais P, Cauchemez B, Macle L, et al. : Atrial fibrillation ablation versus antiarrhythmic drugs: A multicenter randomized trial. in Heart Rhythm Society 2006 Scientific Sessions. 2006. Boston, MA.
36. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL : ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 : e257 e354.
37. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ : Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001 285 : 2864 2870.
38. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B : The ablate and pace trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998 2 : 121 135.
39. Tantengco MV, Thomas RL, Karpawich PP : Left ventricular dysfunction after long-term right ventricular apical pacing in the young. J Am Coll Cardiol 2001 37 : 2093 2100.
40. Statistics Canada. Population by sex and age group. January 2006. Available at : http://www40.statcan.ca101/cst01/demo10a.htm
41. U.S. opportunities in the management of atrial fibrillation. Report #055-1-US-1002 (October 2002), Health Research International. Available at : http://www.healthri.com